ProfileGDS4132 / 47560_at
TitlePPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
OrganismHomo sapiens


pretreatment pioglitazone GSM201542 GSM201543 GSM201544 GSM201545 GSM201829 GSM201830 GSM201831 GSM201832 GSM201833 GSM201834 GSM201835 GSM201836 GSM201837 GSM201838 GSM201839 GSM201840 GSM201841 GSM201842 GSM201843 GSM201844 35% 33% 38% 37% 38% 33% 42% 36% 39% 40% 39% 36% 41% 45% 47% 42% 31% 43% 39% 45% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM201542Muscle PCOS pioglitazone 10188.064735
GSM201543Muscle PCOS pioglitazone 12172.895533
GSM201544Muscle PCOS pioglitazone 16198.485738
GSM201545Muscle PCOS pioglitazone 201103.5937
GSM201829Muscle PCOS pioglitazone 231104.06938
GSM201830Muscle PCOS pioglitazon 25184.688333
GSM201831Muscle PCOS pioglitazone 271108.41642
GSM201832Muscle PCOS pioglitazone 3192.697436
GSM201833Muscle PCOS pioglitazone 4193.824439
GSM201834Muscle PCOS pioglitazone 81100.32640
GSM201835Muscle PCOS after pioglitazone 10285.92439
GSM201836Muscle PCOS after pioglitazone 12281.593336
GSM201837Muscle PCOS after pioglitazone 16290.552241
GSM201838Muscle PCOS after pioglitazone 202106.43445
GSM201839Muscle PCOS after pioglitazone 232118.02347
GSM201840Muscle PCOS after pioglitazone 252106.3342
GSM201841Muscle PCOS after pioglitazone 27263.281831
GSM201842Muscle PCOS after pioglitazone 3293.303943
GSM201843Muscle PCOS after pioglitazone 4296.34839
GSM201844Muscle PCOS after pioglitazone 82114.6345